Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis

Abstract

Treatment-resistant Lyme arthritis is associated with immune reactivity to outer surface protein A (OspA) ofBorrelia burgdorferi, the agent of Lyme disease, and the major histocompatibility complex class II alleleDRB1*0401. The immunodominant epitope of OspA for T helper cells was identified. A homology search revealed a peptide from human leukocyte function–associated antigen-1 (hLFA-1) as a candidate autoantigen. Individuals with treatment-resistant Lyme arthritis, but not other forms of arthritis, generated responses to OspA, hLFA-1, and their highly related peptide epitopes. Identification of the initiating bacterial antigen and a cross-reactive autoantigen may provide a model for development of autoimmune disease.